s6y Allarity Therapeutics, Inc. EFFECT

Allarity Therapeutics, Inc. EFFECT, filed Jun 6, 2022: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 6, 2022
Accession Number: 0001213900-22-030998
Submission Type: POS AM
CIK: 0001860657
Company Name: Allarity Therapeutics, Inc.
File Number: 333-259484